{"id":"https://openalex.org/W4308414142","doi":"https://doi.org/10.3389/fpubh.2022.1015702","title":"Cost-effectiveness analysis of sugemalimab vs. placebo, in combination with chemotherapy, for treatment of first-line metastatic NSCLC in China","display_name":"Cost-effectiveness analysis of sugemalimab vs. placebo, in combination with chemotherapy, for treatment of first-line metastatic NSCLC in China","publication_year":2022,"publication_date":"2022-11-03","ids":{"openalex":"https://openalex.org/W4308414142","doi":"https://doi.org/10.3389/fpubh.2022.1015702","pmid":"https://pubmed.ncbi.nlm.nih.gov/36408023","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9670176"},"language":"en","primary_location":{"id":"doi:10.3389/fpubh.2022.1015702","doi":"https://doi.org/10.3389/fpubh.2022.1015702","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fpubh.2022.1015702","pdf_url":"https://www.frontiersin.org/articles/10.3389/fpubh.2022.1015702/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S2595931848","display_name":"Frontiers in Public Health","issn_l":"2296-2565","issn":["2296-2565"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Public Health","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fpubh.2022.1015702/pdf?isPublishedV2=False","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100318325","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0002-9522-4474","observed_orcids":["https://orcid.org/0000-0002-9522-4474","https://orcid.org/0000-0003-4136-3409","https://orcid.org/0009-0009-9141-6389"]},"institutions":[{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Wei Li","raw_affiliation_strings":["Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I47720641"]},{"raw_affiliation_string":"Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, China","institution_ids":["https://openalex.org/I47720641"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100688630","display_name":"Li Wan","orcid":"https://orcid.org/0000-0003-1004-654X","observed_orcids":["https://orcid.org/0000-0003-1004-654X"]},"institutions":[{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Li Wan","raw_affiliation_strings":["Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I47720641"]},{"raw_affiliation_string":"Department of Pharmacy, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, China","institution_ids":["https://openalex.org/I47720641"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5100318325"],"corresponding_institution_ids":["https://openalex.org/I47720641"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.8789,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.88377084,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"10","issue":null,"first_page":"1015702","last_page":"1015702"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sugemalimab","display_name":"sugemalimab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9179999828338623},{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.9290000200271606},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8989999890327454},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8339999914169312},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.5709999799728394},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.5249999761581421},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.8379999995231628},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8679999709129333},{"id":"https://openalex.org/keywords/patient-assistance-programs","display_name":"patient assistance programs","score":0.9330000281333923},{"id":"https://openalex.org/keywords/china","display_name":"China","score":0.335999995470047}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8374088406562805},{"id":"https://openalex.org/C515549039","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost-effectiveness analysis","level":3,"score":0.5843661427497864},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.5309046506881714},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5031034350395203},{"id":"https://openalex.org/C2779900020","wikidata":"https://www.wikidata.org/wiki/Q6015473","display_name":"Incremental cost-effectiveness ratio","level":4,"score":0.479606032371521},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4594586193561554},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4359097480773926},{"id":"https://openalex.org/C2776125615","wikidata":"https://www.wikidata.org/wiki/Q18391886","display_name":"Economic evaluation","level":2,"score":0.4245436191558838},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.41825225949287415},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4150576889514923},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.404362291097641},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.1735232174396515},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.12470659613609314},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fpubh.2022.1015702","doi":"https://doi.org/10.3389/fpubh.2022.1015702","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fpubh.2022.1015702","pdf_url":"https://www.frontiersin.org/articles/10.3389/fpubh.2022.1015702/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S2595931848","display_name":"Frontiers in Public Health","issn_l":"2296-2565","issn":["2296-2565"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Public Health","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9670176","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9670176","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Public Health","raw_type":"Text"},{"id":"pmid:36408023","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36408023","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in public health","raw_type":"Randomized Controlled Trial"},{"id":"pmh:oai:doaj.org/article:8c4d91cb8e264fbe94d80b06b643d369","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8c4d91cb8e264fbe94d80b06b643d369","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Public Health, Vol 10 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fpubh.2022.1015702","doi":"https://doi.org/10.3389/fpubh.2022.1015702","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fpubh.2022.1015702","pdf_url":"https://www.frontiersin.org/articles/10.3389/fpubh.2022.1015702/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S2595931848","display_name":"Frontiers in Public Health","issn_l":"2296-2565","issn":["2296-2565"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Public Health","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308414142.pdf","grobid_xml":"https://content.openalex.org/works/W4308414142.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W85469694","https://openalex.org/W1997677712","https://openalex.org/W2005295931","https://openalex.org/W2022229528","https://openalex.org/W2272984102","https://openalex.org/W2900705321","https://openalex.org/W2918948206","https://openalex.org/W2964471257","https://openalex.org/W3000746124","https://openalex.org/W3041386602","https://openalex.org/W3134028252","https://openalex.org/W3210599435","https://openalex.org/W4200127049","https://openalex.org/W4205387561","https://openalex.org/W4205569586","https://openalex.org/W4221007196","https://openalex.org/W4224951890","https://openalex.org/W4282041192"],"related_works":["https://openalex.org/W4309567805","https://openalex.org/W4295234064","https://openalex.org/W7155620371","https://openalex.org/W4384408229","https://openalex.org/W7203540927","https://openalex.org/W4312138445","https://openalex.org/W4322217303","https://openalex.org/W4385320483","https://openalex.org/W4378977372","https://openalex.org/W4327977222"],"abstract_inverted_index":{"Objective:":[0],"The":[1],"purpose":[2],"of":[3,11,45,57,122,136,161,167,212,231],"this":[4],"study":[5],"was":[6,48,176,218],"to":[7,50,132,181,223],"estimate":[8],"the":[9,22,52,102,115,134,178,186,191,203,210,216],"cost-effectiveness":[10,54],"sugemalimab":[12],"plus":[13,18],"chemotherapy":[14,19],"(SC)":[15],"vs.":[16,59],"placebo":[17],"(PC),":[20],"as":[21,61,225],"first-line":[23,62,146,226],"treatment":[24,63,227],"for":[25,64,148,228],"patients":[26,65],"with":[27,42,66,144,157,194],"non-small":[28],"cell":[29],"lung":[30],"cancer":[31],"(NSCLC)":[32],"in":[33,95,104,110,164,221],"China.":[34],"Material":[35],"and":[36,80,107,114,126,236],"methods:":[37],"A":[38],"three-state":[39],"Markov":[40],"model":[41,99,137,204],"a":[43,69,86,118,171],"cycle":[44],"3":[46,91],"weeks":[47],"built":[49],"assess":[51],"incremental":[53,159],"ratio":[55],"(ICER)":[56],"SC":[58,147,217],"PC":[60,224],"NSCLC":[67],"over":[68],"10-year":[70],"horizon":[71],"from":[72,85],"Chinese":[73,213],"health":[74,108],"care":[75],"perspective.":[76],"Time-dependency":[77],"transition":[78],"probability":[79],"safety":[81],"data":[82],"were":[83,130,189,206],"derived":[84],"multicenter,":[87],"randomized,":[88],"double-blind,":[89],"phase":[90],"clinical":[92],"trial":[93],"performed":[94],"China":[96],"(GEMSTONE-302).":[97],"Primary":[98],"outcomes":[100,109,205],"included":[101],"costs":[103],"US":[105],"dollars":[106],"quality-adjusted":[111],"life-years":[112],"(QALYs)":[113],"ICER":[116,166,179,187],"under":[117],"willingness-to-pay":[119],"(WTP)":[120],"threshold":[121,193],"$37,663/QALYs.":[123],"Deterministic,":[124],"scenario":[125],"probabilistic":[127],"sensitivity":[128],"analysis":[129,199],"employed":[131],"investigate":[133],"robustness":[135],"outcomes.":[138],"Results:":[139],"In":[140,183],"base-case":[141],"analysis,":[142,185],"compared":[143],"PC,":[145],"intention-to-treat":[149],"(ITT)":[150],"population":[151],"gained":[152],"an":[153,158,165],"additional":[154],"0.57":[155],"QALYs":[156],"cost":[160],"$62,404.15,":[162],"resulting":[163],"$109,480.97/QALYs":[168],"gained.":[169],"When":[170],"patient":[172],"assistance":[173],"program":[174],"(PAP)":[175],"available,":[177],"decreased":[180],"$52,327.02/QALYs.":[182],"subgroup":[184],"values":[188],"above":[190],"WTP":[192],"or":[195],"without":[196],"PAP.":[197],"Sensitivity":[198],"results":[200],"suggested":[201],"that":[202],"reliable.":[207],"Conclusion:":[208],"From":[209],"perspective":[211],"healthcare":[214],"system,":[215],"not":[219],"cost-effective":[220],"comparison":[222],"NSCLC,":[229],"regardless":[230],"PD-L1":[232],"tumor":[233],"expression":[234],"level":[235],"pathological":[237],"subtype.":[238]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-11T00:00:00"}